Search filters

List of works by Jerzy Jaroszewicz

A pill for HCV - myth or foreseeable future?

scientific article published on 02 September 2013

Acute hepatitis E complicated by acute pancreatitis: a case report and literature review.

scientific article published in May 2005

Administration of tocilizumab to patients with high concentrations of IL-6 in the course of COVID-19 is associated with a better prognosis

scientific article published in February 2021

Annex #1 as of 8 June 2020 to: Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020

scientific article published on 08 June 2020

Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation

scientific article

Assessment of serum IGF-1 and adipokines related to metabolic dysfunction in HIV-infected adults.

scientific article published on 12 August 2013

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

scientific article published on 07 February 2020

Chronic HBV infection in patients with lymphoproliferative syndromes

scientific article published in January 2012

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients

scientific article published on 20 February 2019

Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: possible association with hepatic function impairment

scientific article published on 25 July 2008

Clinical Usefulness of the Inhibitory Control Test (ICT) in the Diagnosis of Minimal Hepatic Encephalopathy

scientific article published on 22 May 2020

Clinical importance and diagnostic methods of minimal hepatic encephalopathy

scientific article published on February 2016

Clinical significance of asymptomatic [i]Clostridium difficile[/i] colonisation in patients undergoing antibiotic treatment

scientific article published on 01 January 2020

Clinical value and safety of liver biopsies in patients transplanted for hepatitis C virus-related end-stage liver disease.

scientific article published on 13 November 2014

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

scientific article published on 13 December 2019

Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.

scientific article published in January 2006

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

scientific article published on 26 January 2011

Current drugs in early development for treating hepatitis C virus-related hepatic fibrosis

scientific article published on 30 June 2015

Development and evaluation of a baseline-event-anticipation score for hepatitis delta

scientific article

Development of a protocol for the quantitative determination of HBeAg using the Elecsys® HBeAg immunoassay ⬇️

scientific article published on December 30, 2010

Distribution of HBV genotypes in Poland

scientific article published on 30 April 2015

Does HAART improve renal function? An association between serum cystatin C concentration, HIV viral load and HAART duration

scientific article

Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients

scientific article published on 13 April 2015

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

scientific article

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C - a real-world study

scientific article published on 05 September 2019

Effect of lamivudine treatment on plasma levels of transforming growth factor beta1, tissue inhibitor of metalloproteinases-1 and metalloproteinase-1 in patients with chronic hepatitis B

scientific article

Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

scientific article

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.

scientific article published on 25 December 2012

Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scales.

scientific article

Effect of psoriasis activity on serum adiponectin and leptin levels.

scientific article published on 30 March 2015

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

scientific article

Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study

scientific article published in 2021

Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation.

scientific article

Emerging treatments for hepatitis C.

scientific article published on 08 October 2013

Epidemiological characteristics of inflammatory bowel disease in North-Eastern Poland.

scientific article

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

scientific article published on 01 May 2021

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study

scientific article published in 2019

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

scientific article published in June 2018

HBV mutations associated with lamivudine therapy

scientific article published in January 2013

HBV-DNA and sFas, sFasL concentrations in serum of healthy HBsAg carriers

scientific article published on 01 January 2005

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

scientific article published on 13 January 2022

Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.

scientific article published on 17 February 2015

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

scientific article

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

scientific article published on 13 February 2010

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

scientific article

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

scientific article published in September 2022

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

scientific article published on 15 July 2011

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

scientific article published in March 2012

Hepatitis E virus infection--a new threat for Europe

scientific article published on January 2016

Hepatology topics of special interest from Central Europe (Czech Republic, Hungary, Poland, Slovakia)

scientific article published on 24 March 2016

Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection

scientific article published on 02 June 2015

Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients

scientific article published on 06 November 2012

Increased plasma transforming growth factor-beta1 is associated with disease progression in HIV-1-infected patients.

scientific article published in January 2004

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

scientific article

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

scientific article published on 2 February 2010

Intestinal fatty acid binding protein (I-FABP) as a possible biomarker of ileitis in patients with ulcerative colitis

scientific article published on 15 December 2007

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

scientific article published in February 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

scientific article published on 10 November 2020

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

scientific article published on 13 June 2020

Lymphocyte-To-Monocyte Ratio as the Best Simple Predictor of Bacterial Infection in Patients with Liver Cirrhosis

scientific article published on 06 March 2020

Management of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists. Annex no. 2 as of October 13, 2020

scientific article published on 29 October 2020

Metabolic syndrome and hepatitis C infection – brothers in arms ⬇️

scientific article published on June 19, 2013

Neurological symptoms as a clinical manifestation of COVID-19: implications for internists

scientific article published on 21 August 2020

Normalizing serum hepcidin but not α-1-antitrypsin level during effective treatment of chronic hepatitis C

scientific article published on 16 November 2017

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection

scientific article published on 13 January 2022

Pigment epithelium-derived factor in ulcerative colitis: possible relationship with disease activity.

scientific article

Plasma interleukin-18 is associated with viral load and disease progression in HIV-1-infected patients

scientific article published on 01 November 2004

Plasma interleukin-18 reflects severity of ulcerative colitis.

scientific article

Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.

scientific article

Plasma transforming growth factor beta1, metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 in acute viral hepatitis type B

scientific article published on 01 November 2005

Plasma transforming growth factor-beta(1) in acute viral hepatitis.

scientific article published on 25 May 2005

Predictive power of Model for End-Stage Liver Disease and Child-Turcotte-Pugh score for mortality in cirrhotic patients

scientific article published on 03 December 2018

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland

scientific article

Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation

scientific article published on 05 September 2019

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy

scientific article published on 03 March 2019

Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study

scientific article published on 25 July 2019

Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study.

scientific article published on 9 September 2016

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

scientific article

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)

Recommendations for the treatment of hepatitis B in 2017

scientific article published on 10 May 2017

Recommendations of management in SARS-CoV-2 infection of the Polish Association of Epidemiologists and Infectiologists

scientific article published on 31 March 2020

Remdesivir Decreases Mortality in COVID-19 Patients with Active Malignancy

scientific article published on 28 September 2022

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

scientific article published on 31 December 2020

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

scientific article published on 3 November 2020

SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy

scientific article published on 29 December 2020

Searching for the optimal population for hepatitis C virus screening in Poland

scientific article published on 30 April 2020

Serum Concentrations of Th17-Associated Interleukins and Autoimmune Phenomena are Associated with the Degree of Liver Damage in Alcoholic Liver Disease

scientific article published on September 2017

Serum Cytokeratin 18 M30 Levels in Chronic Hepatitis B Reflect Both Phase and Histological Activities of Disease

scientific article published on 30 July 2017

Serum HCV core antigen concentration in HCV monoinfection and HCV/HIV coinfection

scientific article

Serum adiponectin and leptin levels in psoriatic patients according to topical treatment.

scientific article

Serum cytochrome c and m30-neoepitope of cytokeratin-18 in chronic hepatitis C.

scientific article published on 28 August 2013

Serum prohepcidin reflects the degree of liver function impairment in liver cirrhosis

scientific article published in August 2008

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland

scientific article published on 4 April 2022

Significant Decrease in the Prevalence of Anxiety and Depression after Hepatitis C Eradication

scientific article published in 2022

Soluble immune markers in the different phases of chronic hepatitis B virus infection

scientific article published on 01 October 2019

Specific ssDNA concentration in liver tissue as an index of apoptosis in hepatitis C virus-infected patients.

scientific article published on October 2005

Specifically targeted antiviral therapy for hepatitis C virus

scientific article published on November 2007

Successful antiviral therapy is associated with a decrease of serum prohepcidin in chronic hepatitis C.

scientific article

Surgical treatment of liver tumors - own experience and literature review

scientific article published on 30 January 2017

Symptom-based early-stage differentiation between SARS-CoV-2 versus other respiratory tract infections-Upper Silesia pilot study

scientific article published on 30 June 2021

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease

article

The possible association between serum cholesterol concentration and decreased bone mineral density as well as intravertebral marrow fat in HIV-1 infected patients

scientific article published on 01 February 2007

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

scientific article published on 9 April 2021

Tocilizumab Improves the Prognosis of COVID-19 in Patients with High IL-6

scientific article published in 2021

Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients.

scientific article

Treatment of HCV infection in Poland at the beginning of the interferon-free era - the EpiTer-2 study

scientific article published on 6 January 2018

Treatment recommendations of chronic hepatitis B. Did the world escape us?

scientific article published in January 2008

Update on alisporivir in treatment of viral hepatitis C.

scientific article published on 8 February 2012

[Analysis of prognostic factors in patients with autoimmune hepatitis]

scientific article published on 01 April 2006

[Cytokeratin 18 as an indicator of the activity of liver disease]

scientific article published on 01 December 2011

[Prevalence of antibodies against hepatitis E virus among students from India living in Bialystok, Poland]

scientific article published on 01 January 2008

[The central nervous system and HIV infection]

scientific article published on 01 January 2003

siRNA drug development against hepatitis B virus infection

article

Paulina is supported by:

About Paulina

Help